Literature DB >> 17702194

Pharmacokinetics of astragaloside iv in beagle dogs.

Qi Zhang1, Ling-Ling Zhu, Guo-Guang Chen, Yu Du.   

Abstract

In this study, the pharmacokinetics of Astragaloside iv (AGS-IV) in Beagle dogs was studied by high performance liquid chromatography (HPLC) coupled with tandem mass spectrometry (MS). The concentrations of the drugs in plasma were determined after i.v. administration of 0.5, 1, 2 mg.kg(-1) AGS-IV and p.o. administration of 10 mg.kg(-1) AGS-IV. The areas under concentration-time curve (AUC) were linearly correlated to the doses administrated. The absolute bioavailability of AGS-IV after p.o. administration was found to be 7.4%. The plasma protein binding rate of AGS-IV was about 90% within a concentration range of 250-1000 ng.ml(-1). There was no significant species difference regarding the pharmacokinetics of AGS-IV between the rat and the Beagle dog.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702194     DOI: 10.1007/BF03190995

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  6 in total

1.  Determination of Astragaloside IV in rat plasma by liquid chromatography electrospray ionization mass spectrometry.

Authors:  Yongchuan Gu; Guangji Wang; J Paul Fawcett
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-03-05       Impact factor: 3.205

2.  Quantitation of astragaloside IV in rat plasma by liquid chromatography-tandem mass spectrometry.

Authors:  Li-Xin Yan; De-An Guo
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-09-25       Impact factor: 3.205

3.  Pharmacokinetics of Astragaloside IV in rats by liquid chromatography coupled with tandem mass spectrometry.

Authors:  Y Du; Q Zhang; G G Chen; P Wei; C Y Tu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Oct-Dec       Impact factor: 2.441

4.  Quantitative determination of Astragaloside IV, a natural product with cardioprotective activity, in plasma, urine and other biological samples by HPLC coupled with tandem mass spectrometry.

Authors:  Weidong Zhang; Chuan Zhang; Runhui Liu; Huiliang Li; Jintao Zhang; Chen Mao; Chunlin Chen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-08-05       Impact factor: 3.205

5.  Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali.

Authors:  Yongchuan Gu; Guangji Wang; Guoyu Pan; J Paul Fawcett; Jiye A; Jianguo Sun
Journal:  Basic Clin Pharmacol Toxicol       Date:  2004-12       Impact factor: 4.080

6.  Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.

Authors:  Yumin Luo; Zhen Qin; Zhen Hong; Xinmin Zhang; Ding Ding; Jian-Hui Fu; Wei-Dong Zhang; Jun Chen
Journal:  Neurosci Lett       Date:  2004-06-17       Impact factor: 3.046

  6 in total
  7 in total

1.  Pharmacokinetics Comparison, Intestinal Absorption and Acute Toxicity Assessment of a Novel Water-Soluble Astragaloside IV Derivative (Astragalosidic Acid, LS-102).

Authors:  Lin-Sen Qing; Ting-Bo Chen; Wen-Xia Sun; Li Chen; Pei Luo; Zhi-Feng Zhang; Li-Sheng Ding
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-04       Impact factor: 2.441

Review 2.  A systematic review of anticancer effects of radix astragali.

Authors:  Yeehong Jung; Uimin Jerng; Sookyung Lee
Journal:  Chin J Integr Med       Date:  2015-12-07       Impact factor: 1.978

3.  Astragaloside IV inhibits NF- κ B activation and inflammatory gene expression in LPS-treated mice.

Authors:  Wei-Jian Zhang; Balz Frei
Journal:  Mediators Inflamm       Date:  2015-04-16       Impact factor: 4.711

4.  The Effects of Radix Astragali Water Abstract on Energy Metabolism in Rat Yang-Deficiency Cold Syndrome Model through PPAR Signaling Pathway.

Authors:  Wanchen Yu; Haijun Zhao; Xin Zong; Xuming Ji; Xiaochun Han; Yanfang Wang; Yanan Zhang; Ke Ma; Ning Cui; Shijun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-01       Impact factor: 2.629

5.  Surface-Enhanced Raman Spectroscopy Analysis of Astragalus Saponins and Identification of Metabolites After Oral Administration in Rats by Ultrahigh-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry Analysis.

Authors:  Shengnan Kong; Shan Ou; Yan Liu; Minzhen Xie; Ting Mei; Yingshuo Zhang; Jincheng Zhang; Qi Wang; Bingyou Yang
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

6.  Alendronate modified mPEG-PLGA nano-micelle drug delivery system loaded with astragaloside has anti-osteoporotic effect in rats.

Authors:  Yanhai Xi; Weiheng Wang; Liang Ma; Ning Xu; Changgui Shi; Guohua Xu; Hailong He; Wenming Pan
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 7.  Anti-Aging Implications of Astragalus Membranaceus (Huangqi): A Well-Known Chinese Tonic.

Authors:  Ping Liu; Haiping Zhao; Yumin Luo
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.